MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)

MMC、VICC

• 批准号: 9211638
• 负责人: Samuel Evans Adunyah
• 金额: $ 140.15万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-26 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9211638
• 关键词: Address; Advisory Committees; African American; Age; Award; Awareness; Basic Science; Bioinformatics; Biometry; Cancer Burden; Cancer Center; Clinical Research; Clinical Trials; Collaborations; Communities; Community Health; Community Health Education; Core Facility; Development; Diagnosis; Discipline; Education; Education and Outreach; Effectiveness; Environment; Faculty; Fostering; General Hospitals; Goals; Growth; Health Educators; Incidence; Institution; Joints; Malignant Neoplasms; Measurable; Medical Students; Minority; Minority-Serving Institution; Mission; Monitor; NCI Center for Cancer Research; NCI-Designated Cancer Center; Outcome; Pathology; Pathway interactions; Peer Review; Population; Publications; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Series; Tennessee; Translational Research; Triad Acrylic Resin; Underrepresented Minority; Universities; Work; anticancer research; base; cancer education; cancer health disparity; cancer therapy; cancer type; career; career development; community organizations; design; disparity reduction; education research; graduate student; health disparity; healthcare community; high school; improved; improved outcome; medical schools; mortality; multidisciplinary; oncology; outreach; outreach program; programs; research and development; underserved minority

SUMMARY Particular emphasis is devoted in the US to identify the determinants of, and eventually remedies, for the disproportionate share of the cancer burden borne by underrepresented minorities. Incidence rates for many forms of cancer are higher among blacks than whites. The disparity is compounded by lower rates of relative survival for almost all cancers, so that age-adjusted mortality rates are substantially higher among African Americans than whites for about two-thirds of all types of cancers. Our Cancer Partnership provides an exceptional environment to focus the efforts of diverse investigators working across many disciplines to address health disparities in NCI designated cancer centers and to develop research infrastructure, capacity and effectiveness of minority-serving institutions. Collectively, these efforts offer the best opportunity to overcome cancer disparities and optimize research resources and infrastructure. Our Partnership has matured and developed strong, successful collaborative interactions based on excellence, true reciprocity and mutual benefit to achieve this goal. Moreover, this Partnership is geographically placed in a region with the highest cancer incidence in the US, pointing to the enormous potential for improved outcomes through the proposed work. We are dedicated to enhancing the strengths and eliminating the weaknesses of our three institutions as we move toward our shared goal of eliminating cancer disparities. The overall objectives of this competing renewal application are to: (1) increase and stabilize the competitive cancer research capability of Meharry Medical College (MMC) and Tennessee State University (TSU); (2) create stable, long-term collaborative relationships between MMC, TSU and the Vanderbilt Ingram Cancer Center (VICC) in cancer research, research education, career development and cancer outreach; (3) expand access to clinical trials for minority populations served by Nashville General Hospital (NGH)/MMC, and (4) improve the effectiveness of VICC research, career development, education and outreach activities specifically designed to benefit minority populations served by VICC. All activities will be monitored by an Internal Advisory Committee and the Program Steering Committee with representation from the NCI. A sustained and comprehensive Cancer Partnership is of immense benefit to the three participating institutions as well as the mid-South region of the US. The common mission statement for our Cancer Partnership is to conduct rigorous basic, translational and clinical research directed towards the reduction of disparities in the incidence and treatment of cancer through a multidisciplinary collaborative approach to research, education and community engagement. As a triad we will amplify cancer research capabilities in the greater Nashville academic and healthcare community, improve and document outcomes in the diagnosis and treatment of cancer in minority and underserved communities, minimize or eliminate measurable disparities in the incidence of cancer among minority populations, and fortify collaborations among the three partner organizations.

摘要 在美国，特别强调的是确定决定因素，并最终确定补救措施 不成比例的癌症负担由代表不足的少数族裔承担。许多人的发病率 黑人患癌症的比例比白人高。较低的相对率加剧了这种差距。 几乎所有癌症的存活率，因此非洲人的年龄调整死亡率要高得多 在所有类型的癌症中，美国人比白人高出约三分之二。我们的癌症合作伙伴关系提供了 特殊的环境，使跨多个学科的不同调查人员的努力集中到 解决国家癌症研究所指定癌症中心的健康差距问题，并发展研究基础设施、能力 以及为少数群体服务的机构的有效性。总的来说，这些努力提供了最好的机会 克服癌症差异，优化研究资源和基础设施。我们的伙伴关系已经成熟 并在卓越、真正的互惠和相互的基础上开发了强大、成功的协作互动 有利于实现这一目标。此外，这一伙伴关系的地理位置是世界上 美国的癌症发病率，表明通过拟议的 工作。我们致力于加强和消除我们三个机构的优势和劣势： 我们朝着消除癌症差异的共同目标前进。本次大赛的总体目标是 续签申请：(1)增加和稳定Meharry具有竞争力的癌症研究能力 医学院(MMC)和田纳西州立大学(TSU)；(2)创建稳定、长期的合作 MMC、TSU和Vanderbilt Ingram癌症中心(VICC)在癌症研究中的关系 研究教育、职业发展和癌症外展；(3)扩大少数族裔获得临床试验的机会 由纳什维尔综合医院(NGH)/MMC服务的人群，以及(4)提高VICC的有效性 专门为少数群体设计的研究、职业发展、教育和外联活动 VICC服务的人群。所有活动将由内部咨询委员会和 由NCI代表组成的计划指导委员会。一种持续的全面癌症 伙伴关系对三个参与机构以及中南地区都大有裨益。 我们。我们癌症伙伴关系的共同使命声明是进行严格的基础、翻译和 旨在通过以下途径减少癌症发病率和治疗差异的临床研究 研究、教育和社区参与的多学科协作方法。作为一个三合会成员，我们 将扩大纳什维尔学术和医疗保健社区的癌症研究能力，改善 并记录少数族裔和服务不足社区的癌症诊断和治疗成果， 最大限度地减少或消除少数群体癌症发病率的可测量差异，并加强 三个伙伴组织之间的协作。